PP
RARE icon

Paloma Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Paloma Partners’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,182
Closed -$579K – 2307
2020
Q4 		$579K Buy
+4,182
New +$496K 0.02% 832
2020
Q1 		– Sell
-18,746
Closed -$801K – 1923
2019
Q4 		$801K Buy
+18,746
New +$773K 0.01% 1097
2018
Q4 		– Sell
-4,494
Closed -$343K – 1692
2018
Q3 		$343K Buy
+4,494
New +$366K 0.01% 1177
2018
Q2 		– Sell
-10,095
Closed -$514K – 2098
2018
Q1 		$514K Sell
10,095
-2,401
-19% -$121K 0.01% 1356
2017
Q4 		$580K Buy
+12,496
New +$613K 0.01% 1282
2016
Q3 		– Sell
-7,398
Closed -$362K – 2071
2016
Q2 		$362K Buy
+7,398
New +$479K ﹤0.01% 1690

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return